Lung Cancer Radiation Treatment

 Lung Cancer Radiation Treatment

Breast Cancer Cost Treatment
Breast Cancer Information Treatment
Advance Cancer In Ovarian Treatment
Colon Cancer Alternative Treatment
Cancer Colon Condition More Treatment
Pancreatic Cancer Treatment
Radiation Treatment For Thyroid Cancer
Cancer Center Liver Treatment
Cancer Treatment Center Chicago
Cancer Treatment Center Tulsa
Cancer From Healing Journey
Asbestos Cancer Lung Treatment
Breast Cancer Treatment Option
Cancer Hormone Prostate Therapy Treatment
Natural Cancer Remedy
Breast Cancer Stage Treatment
Alternative Bladder Cancer Treatment
Advanced Cancer Lung Treatment
Cancer Cervical Radiation Therapy
4 Cancer Lung Stage Treatment
Cancer Liver Secondary Treatment
Alternative Breast Cancer Medicine Treatment
Cancer And Natural Medicine
Hormone Therapy Prostrate Cancer
Breast Cancer Latest Treatment
Breast Cancer New Treatment
Alternative Cancer Localized Prostate Treatment
Lung Cancer Radiation Therapy
Skin Cancer Treatment



 

 

Accuray Exceeds 4,000 Lung Cancer Patients Treated with CyberKnife(R ...

SUNNYVALE, Calif., Nov. 16 /PRNewswire-FirstCall/ -- Accuray Incorporated (NASDAQ: ARAY) , a global leader in the field of radiosurgery, today announced that its CyberKnife(R) Robotic Radiosurgery System has been used to treat more than 4,000 lung cancer patients worldwide. The company also reported that more than 40,000 patients in total have been treated with CyberKnife radiosurgery for tumors throughout the body.

In April 2007, Accuray announced that the number of lung tumor patients treated with the CyberKnife System had surpassed 2,000. In the span of seven months, that number doubled, demonstrating the growing clinical adoption of this treatment modality in lung cancer care.

This significant growth is due in part to the increasing availability of Accuray's unparalleled lung cancer treatment offerings at CyberKnife centers.


Metastatic colorectal cancer - NICE: insufficient evidence to ...

The Appraisal Committee has prepared a Final Appraisal Determination on the use of Avastin and Erbitux in metastatic colorectal cancer and submitted it to the Institute.

The main recommendations made are as follows:


Avastin ( Bevacizumab ) in combination with 5-FluoroUracil plus Folinic Acid, with or without Irinotecan, is not recommended for the first-line treatment of metastatic colorectal cancer.

Erbitux ( Cetuximab ) in combination with Irinotecan is not recommended for the second-line or subsequent treatment of metastatic colorectal cancer.

People currently receiving Bevacizumab or Cetuximab should have the option to continue therapy until they and their consultants consider it appropriate to stop.


The management of metastatic colorectal cancer is mainly palliative and involves a combination of treatments ( such as palliative surgery, chemotherapy and radiation ), symptom control and psychosocial support.


In the Box: NFL Week 11

I'm throwing in the towel on the Bengals. Their defense is just too terrible. And their offensive line stinks, too. Marvin Lewis has lost this team.

On the other side, Arizona's final six: San Francisco, Cleveland, at Seattle, at New Orleans, Atlanta, St. Louis.

Seattle's final six: at St. Louis, at Philadelphia, Arizona, at Carolina, Baltimore, at Atlanta.

With four home games for the Cardinals to only two for Seattle (a bad road team), the overall edge goes to Arizona. With that said, the biggest game remaining for each team, the re-match of a Week 2 Arizona win, will be at Qwest in Week 14. Chances are the winner of that one takes the division.

Fantasy Impact: What? You were expecting Leonard Pope to put up two touchdowns every week?

NY Jets 19, Pittsburgh 16: The Steelers' three losses this year: Arizona, Denver, and the Jets, all on the road.



 

 

 

Link to us - Contact us